Chinese-american Biopharmaceutical Society
Nonprofit profile at a glance
- EIN
- 202246060
- IRS 990 coverage
- 2023–2023
- Forms available
- Form 990 2023, Form 990-EZ 2022
- Location
- San Francisco, CA, USA
- Phone
- 6508926283
- Rating
- 77
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Biological & Life Sciences
Reported finances
- Revenue
- $230,254
- Expenses
- $244,893
- Assets
- $290,662
- Liabilities
- $2,500
Source: IRS Form 990. Selected filing: tax year 2023. Amounts in USD.
Leadership & pay
13 people listed
Executive titles in this filing
- Jessica Sun (President & Dir)
- Kay Tong (President Elect)
People named in this filing
- Yan Wang (Director)
- Alan Hao (Director)
- Cheni Kwok (Director)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990. Selected filing: tax year 2023. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The Chinese American Biopharmaceutical Society (CABS) is a non-profit organization for professional in the biopharmaceutical industry. CABS is highly influential association with more than 3,000 members and subscribers in the life science industry. About 70% of our members have PhD degree relating to life sciences. A considerable proportion of the members are holding senior research and management positions in American and multi-national life science corporations. We organize many activities to promote international collaborations in life sciences and to provide Science & Technology Parks and life sciences companies in the Pacific Rim with an excellent platform to promote business and to recruit talent. CABS is helping members seeking collaboration opportunities in the Pacific Rim. To further meet the needs of CABS members, we are actively helping our members seeking partnership opportunities in the Pacific Rim: To co-sponsor scientific conference in biopharmaceutical fieldTo organize C
What it reported doing in 2023
CABS Annual Conference: Program Revenue: $12,576 Program Expenses: $193,678
Operating model
- Revenue model
- Membership-supported. 90% of the money available for current operations came from membership dues.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Some filing-based governance responses are negative or unanswered and expenses are high relative to revenue.
Rating breakdown
- Financial Efficiency: 83
- Transparency & Controls: 90
- Accountability: 58
- Sustainability: 41
- Growth: 60
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 95.2%; rating input score 95
- Program expense ratio: 89.5%; rating input score 90
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
- Pay-setting controls: Limited
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Limited
- Related-party transparency: Limited
Accountability
- Independent voting board: 100%; rating input score 100; 63rd percentile among comparable filings
- Governance controls: 0 of 7 controls in place; rating input score 0
- Conflict-of-interest policy: Fail
- Whistleblower policy: Fail
- Document-retention policy: Fail
- CEO compensation review process: NotApplicable
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Fail
- Board meeting minutes documented: Fail
- Audit committee oversight: Missing
- Independent financial-statement audit: Fail
Sustainability
- Operating margin: -6.4%; rating input score 29; 29th percentile among comparable filings
- Total-asset coverage ratio: 1.19; rating input score 45; 45th percentile among comparable filings
- Liabilities to assets ratio: 0.01; rating input score 49; 49th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 69; 69th percentile among comparable filings
Growth
- Program expense growth: Limited
- Revenue growth: 2.2% per year; rating input score 100; 39th percentile among comparable filings
- Asset growth: 10.2% per year; rating input score 100; 66th percentile among comparable filings
Details
- Where the money goes: 95.2% of revenue deployed · 89.5% of spending went to programs
- Governance: 13 of 13 board members independent · 0 of 7 filing controls reported
- Programs: 3 filed program accomplishments · $219K in reported program spending
- Leadership: top reported pay $0 · 13 people listed
- Consistency: 15 of 15 current checks pass
- Schedules: 2 filed schedules
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
Grant-readiness screening is separate from the live rating, not a measure of program quality. Review the source records before making a grant decision.
- High — Accountability: Governance controls: 6 of 6 not reported.
- High — Sustainability: Operating margin scored 29/100.
- Moderate — Sustainability: Total-asset coverage ratio scored 45/100.
- Moderate — Sustainability: Liabilities to assets ratio scored 49/100.
- Review — Grant Readiness: California registration: this organization could not be resolved against the register, so the check is unfinished.